enow.com Web Search

  1. Ads

    related to: what is braf positive melanoma

Search results

  1. Results from the WOW.Com Content Network
  2. BRAF (gene) - Wikipedia

    en.wikipedia.org/wiki/BRAF_(gene)

    BRAF is a human gene that ... The positive charge on the primary amine of K483 allows it to stabilize the ... B-Raf increased metastatic melanoma patient chance of ...

  3. V600E - Wikipedia

    en.wikipedia.org/wiki/V600E

    V600E is a mutation of the BRAF gene in which valine (V) is substituted by glutamic acid (E) at amino acid 600. [1] [2] It is a driver mutation in a proportion of certain diagnoses, including melanoma, [3] [4] hairy cell leukemia, [5] [6] papillary thyroid carcinoma, [7] [8] colorectal cancer, [9] non-small-cell lung cancer, [10] [11] Langerhans cell histiocytosis, [12] Erdheim–Chester ...

  4. Vemurafenib - Wikipedia

    en.wikipedia.org/wiki/Vemurafenib

    Vemurafenib only works in melanoma patients whose cancer has a V600E BRAF mutation (that is, at amino acid position number 600 on the B-Raf protein, the normal valine is replaced by glutamic acid). [4] About 60% of melanomas have this mutation. It also has efficacy against the rarer V600K BRAF (the normal valine is replaced by lysine) mutation ...

  5. GlaxoSmithKline Begins Phase 3 Melanoma Study - AOL

    www.aol.com/news/2013-02-04-glaxosmithkline...

    Pharmaceutical giant GlaxoSmithKline announced in a press release that it has begun a phase 3 study to find out whether two of its drugs -- its BRAF inhibitor dabrafenid and MEK inhibitor ...

  6. Melanoma - Wikipedia

    en.wikipedia.org/wiki/Melanoma

    BRAF inhibitors, such as vemurafenib and dabrafenib and a MEK inhibitor trametinib are the most effective, approved treatments for BRAF positive melanoma. [ 131 ] [ 124 ] Melanoma tumors can develop resistance during therapy which can make therapy no longer effective, but combining the use of BRAF and MEK inhibitors may create a fast and ...

  7. Encorafenib - Wikipedia

    en.wikipedia.org/wiki/Encorafenib

    Encorafenib is indicated in combination with binimetinib, for the treatment of people with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test; [2] in combination with cetuximab, for the treatment of adults with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test, after prior therapy; [2] in ...

  1. Ads

    related to: what is braf positive melanoma